BioCardia
BCDA
12 hedge funds and large institutions have $2.85M invested in BioCardia in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, 3 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
434% more capital invested
Capital invested by funds: $534K → $2.85M (+$2.31M)
71% more funds holding
Funds holding: 7 → 12 (+5)
0.48% more ownership
Funds ownership: 0.16% → 0.63% (+0.48%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$2.38M |
| 2 |
RAM
Roumell Asset Management
Chevy Chase,
Maryland
|
+$1.2M |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$88.1K |
| 4 |
Jane Street
New York
|
+$53K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$21.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$53.8K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$25.6K |
| 3 |
Morgan Stanley
New York
|
-$2.33K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $1.61M | +$2.38M | +43,945 | New |
|
|
RAM
2
Roumell Asset Management
Chevy Chase,
Maryland
| $796K | +$1.2M | +22,200 | New |
|
|
3
Osaic Holdings
Scottsdale,
Arizona
| $204K | -$25.6K | -472 | -8% |
|
4
Brown Advisory
Baltimore,
Maryland
| $79K | – | – | – |
|
|
CH
5
CVI Holdings
Wilmington,
Delaware
| $58K | +$88.1K | +1,627 | New |
|
|
6
Millennium Management
New York
| $41K | -$53.8K | -994 | -46% |
|
|
7
Jane Street
New York
| $35K | +$53K | +979 | New |
|
|
8
Bank of America
Charlotte,
North Carolina
| $14K | +$21.2K | +392 | New |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $6K | +$9.37K | +173 | New |
|
|
10
Morgan Stanley
New York
| $1K | -$2.33K | -43 | -54% |
|
|
11
UBS Group
Zurich,
Switzerland
| – | -$1K | -17 | Closed |
|
BCDA Hedge Fund Activity: Q2 2020 in Review
12 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q2 2020, worth a combined $2.85M — up 434% from $534K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new BCDA positions and 1 closed out — a net gain of 5 holders — while 0 added to existing stakes and 3 trimmed.
The largest buyer was CAPTRUST Financial Advisors, opening a new position worth an estimated $2.38M. The largest seller was Millennium Management, cutting an estimated $53.8K.
- 12 institutional investors held BioCardia (BCDA) as of Q2 2020, up from 7 in Q1 2020.
- Funds reported $2.85M of BioCardia stock for Q2 2020, up 434% quarter-over-quarter.
- 6 funds opened new BioCardia positions in Q2 2020 and 1 closed out, a net change of +5 holders.
- The largest BioCardia buyer in Q2 2020 was CAPTRUST Financial Advisors, an estimated $2.38M added.
- The largest BioCardia seller in Q2 2020 was Millennium Management, an estimated $53.8K sold.
Based on aggregated 13F filings for Q2 2020.